An audit of toxicity from first-line immunotherapy in inoperable or metastatic non-small cell lung cancer patients divided by ECOG performance status

Autor:	M. Gibb, S. Massalha, C. Bale
Rok vydání:	2020
Předmět:	Pulmonary and Respiratory Medicine Oncology Cancer Research medicine.medical_specialty business.industry First line medicine.medical_treatment ECOG Performance Status Audit Immunotherapy medicine.disease Internal medicine Toxicity Medicine Non small cell business Lung cancer
Zdroj:	Lung Cancer. 139:S56
ISSN:	0169-5002
DOI:	10.1016/s0169-5002(20)30157-4
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e46dc61eeecb8327c6190e6e4994056c https://doi.org/10.1016/s0169-5002(20)30157-4 Zobrazit plný text záznamu Full Text from ScienceDirect